IDR
Idaho Strategic Resources, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-22 | Turner Carolyn S |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-01-16 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Sell↓
Filing footnotes — Common stock (Direct)
This transaction completes the sale of 14,243 common shares disclosed on Form 144 filed by Mr. Brackebusch on January 16, 2026. |
Common stock
|
14,243 |
| 2026-01-07 | Swallow John |
Director, President & CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects 2,688 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 11,500 stock option owned by the Reporting Person pusuant to the Issuer's 2023 Equity Incentive Plan. |
Common Stock
|
11,500 |
| 2026-01-07 | Swallow John |
Director, President & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects 2,688 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 11,500 stock option owned by the Reporting Person pusuant to the Issuer's 2023 Equity Incentive Plan. |
Common Stock
|
2,688 |
| 2026-01-07 | Hayes Monique D |
Corporate Secretary |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects 1,520 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 6,500 stock option owned by the Reporting Person pursuant to the Issuer's 2023 Equity Incentive Plan. |
Common Stock
|
1,520 |
| 2026-01-07 | Swallow John |
Director, President & CEO |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 2,688 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 11,500 stock option owned by the Reporting Person pusuant to the Issuer's 2023 Equity Incentive Plan. |
Stock Options
|
5,750 |
| 2026-01-07 | Hayes Monique D |
Corporate Secretary |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects 1,520 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 6,500 stock option owned by the Reporting Person pursuant to the Issuer's 2023 Equity Incentive Plan. |
Common Stock
|
6,500 |
| 2026-01-07 | Hayes Monique D |
Corporate Secretary |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 1,520 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 6,500 stock option owned by the Reporting Person pursuant to the Issuer's 2023 Equity Incentive Plan. |
Stock Options
|
3,250 |
| 2026-01-07 | Hayes Monique D |
Corporate Secretary |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 1,520 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 6,500 stock option owned by the Reporting Person pursuant to the Issuer's 2023 Equity Incentive Plan. |
Stock Options
|
3,250 |
| 2026-01-07 | Swallow John |
Director, President & CEO |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 2,688 stock options retired by issuer at the market price of $49.20 per share less an exercise price of $11.50 per share to fund the cashless exercise of 11,500 stock option owned by the Reporting Person pusuant to the Issuer's 2023 Equity Incentive Plan. |
Stock Options
|
5,750 |
| 2026-01-05 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Convert↑
Filing footnotes — Common Stock (Direct)
Reporting person exercised 11,500 stock options at an exercise price of $11.50 per share, granted on January 15, 2025 persuant to the Issuer's 2023 Equity Incentive Plan. |
Common Stock
|
11,500 |
| 2026-01-05 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Convert↓
Filing footnotes — Stock Options (Direct)
Reporting person exercised 11,500 stock options at an exercise price of $11.50 per share, granted on January 15, 2025 persuant to the Issuer's 2023 Equity Incentive Plan. |
Stock Options
|
5,750 |
| 2026-01-05 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Convert↓
Filing footnotes — Stock Options (Direct)
Reporting person exercised 11,500 stock options at an exercise price of $11.50 per share, granted on January 15, 2025 persuant to the Issuer's 2023 Equity Incentive Plan. |
Stock Options
|
5,750 |
| 2025-12-30 | Swallow John |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
These transactions complete the sale of 20,000 common shares disclosed on Form 144 filed by Mr. Swallow on December 30 2025. |
Common Stock
|
20,000 |
| 2025-12-22 | Swallow John |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
These transactions complete the sale of 30,000 common shares disclosed on Form 144 filed by Mr. Swallow on December 22, 2025. |
Common Stock
|
30,000 |
| 2025-11-18 | Beaven Richard Scott |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These transactions complete the sale of 2,000 common shares disclosed on From 144 filed November 18, 2025 by Mr. Beaven |
Common Stock
|
2,000 |
| 2025-09-23 | Swallow John |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
These transactions complete the sale of 87,470 common shares disclosed on From 144 filed September 23, 2025 by Mr. Swallow |
Common Stock
|
38,848 |
| 2025-09-23 | Swallow John |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
These transactions complete the sale of 87,470 common shares disclosed on From 144 filed September 23, 2025 by Mr. Swallow |
Common Stock
|
48,622 |
| 2025-09-22 | Morgan Robert John |
VP Exploration |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction completes the sale of 7,143 common shares disclosed on From 144 filed September 22, 2025 by Mr. Morgan |
Common Stock
|
7,143 |
| 2025-09-19 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction completes the sale of 15,937 common shares disclosed on From 144 on September 19, 2025 by Ms. Brackebusch. |
Common Stock
(I)
|
15,937 |
| 2025-08-29 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Convert↓
Filing footnotes — Stock Options (Direct)
Reporting person exercised 3,000 stock options at an exercise price of $5.25 per share, granted on September 6, 2022 persuant to the Issuer's 2014 Equity Incentive Plan |
Stock Options
|
3,000 |
| 2025-08-29 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Convert↑
Filing footnotes — Common Stock (Direct)
Reporting person exercised 3,000 stock options at an exercise price of $5.25 per share, granted on September 6, 2022 persuant to the Issuer's 2014 Equity Incentive Plan |
Common Stock
|
3,000 |
| 2025-08-28 | Swallow John |
Director, President & CEO |
Convert↓
Filing footnotes — Stock Options (Direct)
Reporting person exercised 3,000 stock options at an exercise price of $5.77 per share, granted on September 6, 2022 persuant to the Issuer's 2014 Equity Incentive Plan |
Stock Options
|
3,000 |
| 2025-08-28 | Swallow John |
Director, President & CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
Reporting person exercised 3,000 stock options at an exercise price of $5.77 per share, granted on September 6, 2022 persuant to the Issuer's 2014 Equity Incentive Plan |
Common Stock
|
3,000 |
| 2025-08-25 | Morgan Robert John |
VP Exploration |
Convert↑
Filing footnotes — Common Stock (Direct)
On August 25, 2025 Robert Morgan exercised 3,000 stock options granted on September 6, 2022 persuant to the Issuer's 2014 Equity Incentive Plan with an exercise price of $5.25. |
Common Stock
|
3,000 |
| 2025-08-25 | Morgan Robert John |
VP Exploration |
Convert↓
Filing footnotes — Stock Options (Direct)
On August 25, 2025 Robert Morgan exercised 3,000 stock options granted on September 6, 2022 persuant to the Issuer's 2014 Equity Incentive Plan with an exercise price of $5.25. |
Stock Options
|
3,000 |
| 2025-08-19 | Swallow John |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
42,231shares of common stock sold in this transaction were acquired by Mr. Swallow in a private acquisition from the issuer on August 30, 2013 and 7,769 shares of common stock sold by Mr. Swallow were acquired in a private acquisition from the issuer on January 29, 2014. This transaction completes the sale of 50,000 common shares disclosed on From 144 filed on August 19, 2025 by Mr. Swallow. |
Common Stock
|
50,000 |
| 2025-08-11 | Shiell Kevin G |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Shares sold in this transaction were acquired on March 28, 2017 through a private placement with the Registrant. This transaction completes the sale of 14,286 common shares disclosed on Form 144 filed on May 21, 2025 The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 6,500 shares is from $24.31 to $25.45. The filing person will provide full information regarding the number of shares sold at each separate price upon request from the SEC, or a shareholder of the Registrant |
Common Stock
|
6,500 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The Reporting Person exercised 5,000 stock options with and exercise price of $4.75. This is a partial exercise of the full grant of 7,500 stock options on 9/28/2022 pursuant to the Issuer's 2014 Equity Incentive Plan. The remaining 2,500 stock options were exercised cashless at the same time. |
Common Stock
|
5,000 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects 751 stock options retired by the Issuer at the market price of $20.98 per share, less an exercise price of $5.25 per share to fund the cashless exercise of 3,000 stock options owned by the Reporting Person pursuant to the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
751 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects 751 stock options retired by the Issuer at the market price of $20.98 per share, less an exercise price of $5.25 per share to fund the cashless exercise of 3,000 stock options owned by the Reporting Person pursuant to the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
3,000 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects 566 stock options retired by the Issuer at the market price of $20.98 per share, less an exercise price of $4.75 per share to fund the cashless exercise of 2,500 stock options owned by the Reporting Person pursuant to the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
2,500 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects 566 stock options retired by the Issuer at the market price of $20.98 per share, less an exercise price of $4.75 per share to fund the cashless exercise of 2,500 stock options owned by the Reporting Person pursuant to the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
566 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
The Reporting Person exercised 5,000 stock options with and exercise price of $4.75. This is a partial exercise of the full grant of 7,500 stock options on 9/28/2022 pursuant to the Issuer's 2014 Equity Incentive Plan. The remaining 2,500 stock options were exercised cashless at the same time. Reflects 566 stock options retired by the Issuer at the market price of $20.98 per share, less an exercise price of $4.75 per share to fund the cashless exercise of 2,500 stock options owned by the Reporting Person pursuant to the Issuer's 2014 Equity Incentive Plan. |
Stock Options
|
7,500 |
| 2025-07-21 | Beaven Richard Scott |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 751 stock options retired by the Issuer at the market price of $20.98 per share, less an exercise price of $5.25 per share to fund the cashless exercise of 3,000 stock options owned by the Reporting Person pursuant to the Issuer's 2014 Equity Incentive Plan. |
Stock Options
|
3,000 |
| 2025-07-18 | Shiell Kevin G |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects 874 stock options retired by issuer at the market price of $18.02 per share less an exercise price of $5.25 per share to fund the cashless exercise of 3,000 stock options owned by the Reporting Person pursuant the the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
3,000 |
| 2025-07-18 | Shiell Kevin G |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects 874 stock options retired by issuer at the market price of $18.02 per share less an exercise price of $5.25 per share to fund the cashless exercise of 3,000 stock options owned by the Reporting Person pursuant the the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
874 |
| 2025-07-18 | Shiell Kevin G |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects 1,977 stock options retired by issuer at the market price of $18.02 per share less an exercise price of $4.75 per share to fund the cashless exercise of 7,500 stock options owned by the Reporting Person pursuant the the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
1,977 |
| 2025-07-18 | Hayes Monique D |
Corporate Secretary |
Sell↓
Filing footnotes — Common Shares (Direct)
The 4,829 shares of Common Stock sold by Ms. Hayes were purchased in the open market on March 6, 2017. This transaction completes the sale of 4,829 common shares disclosed on From 144 on July 18, 2025 by Ms. Hayes. |
Common Shares
|
4,829 |
| 2025-07-18 | Shiell Kevin G |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 1,977 stock options retired by issuer at the market price of $18.02 per share less an exercise price of $4.75 per share to fund the cashless exercise of 7,500 stock options owned by the Reporting Person pursuant the the Issuer's 2014 Equity Incentive Plan. |
Stock Options
|
7,500 |
| 2025-07-18 | Shiell Kevin G |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects 1,977 stock options retired by issuer at the market price of $18.02 per share less an exercise price of $4.75 per share to fund the cashless exercise of 7,500 stock options owned by the Reporting Person pursuant the the Issuer's 2014 Equity Incentive Plan. |
Common Stock
|
7,500 |
| 2025-07-18 | Shiell Kevin G |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Reflects 874 stock options retired by issuer at the market price of $18.02 per share less an exercise price of $5.25 per share to fund the cashless exercise of 3,000 stock options owned by the Reporting Person pursuant the the Issuer's 2014 Equity Incentive Plan. |
Stock Options
|
3,000 |
| 2025-07-10 | Swallow John |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction completes the sale of 100,000 common shares disclosed on From 144 on July 10, 2025 by Mr. Swallow |
Common Stock
|
100,000 |
| 2025-07-10 | Hayes Monique D |
Corporate Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction completes the sale of 12,724 common shares disclosed on From 144 on July 10, 2025 by Ms. Hayes |
Common Stock
|
12,724 |
| 2025-05-23 | Shiell Kevin G |
Director |
Sell↓
|
Common Stock
|
3,500 |
| 2025-05-22 | Shiell Kevin G |
Director |
Sell↓
|
Common Stock
|
1,000 |
| 2025-05-21 | Shiell Kevin G |
Director |
Sell↓
|
Common Stock
|
3,286 |
| 2025-01-15 | Shiell Kevin G |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On January 15, 2025, Mr. Shiell was granted 10,000 stock options. These options vest in equal amounts bi-annually on July 15, 2025 and January 15, 2026 |
Stock Option (Right to Buy)
|
5,000 |
| 2025-01-15 | BRACKEBUSCH GRANT A |
Director, CFO/Vice President |
Award↑
Filing footnotes — Stock option (Right to Buy) (Direct)
On January 15, 2025, Mr. Brackebusch was granted 23,000 stock options. These options vest in equally amounts bi-annually on July 15, 2025 and January 15, 2026, respectively, up to a maximum fair market value a total of $100,000 per calendar year. |
Stock option (Right to Buy)
|
9,727 |
| 2025-01-15 | Swallow John |
Director, President & CEO |
Award↑
Filing footnotes — Stock option (Right to Buy) (Direct)
On January 15, 2025, Mr. Swallow was granted 23,000 stock options. The original Form 4, filed on January 16, 2025, is being amended by this Form 4 amendment solely to correct a scrivener's error, which misreported the Exercise Prices of the Stock Options granted as $1,150 when in fact the Exercise Prices under Table II, Item 2 are $11.50. These options vest in equally amounts bi-annually on July 15, 2025 and January 15, 2026, respectively, up to a maximum fair market value a total of $100,000 per calendar year. The fair market value of the options was determined to be the closing price of the stock on January 14, 2025 of $10.28. Therefore, 9,727 options vest on July 15, 2025 and on January 15, 2026, and the remaining stock options on January 1, 2027. |
Stock option (Right to Buy)
|
3,546 |